Transfusion Clinique et Biologique

Article	Citations
The blood supply management amid the COVID-19 outbreak	57
ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population	42
The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region	40
Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand	25
COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?	20
“Because Every Drop Counts”: Blood donation during the COVID-19 Pandemic	20
Post-donation information and haemovigilance reporting for COVID-19 in Greece: Information supporting the absence of SARS-CoV-2 possible transmission through blood components	15
Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency	13
Transfusion and sickle cell anemia in Africa	13
Assessment of blood supply and usage pre- and during COVID-19 pandemic: A lesson from non-voluntary donation	13
The chronicles of blood banking in India	11
Storage of red blood cell concentrates: Clinical impact	9
Convalescent Plasma Therapy in the management of COVID-19 patients-The newer dimensions	9
Covid-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India	8
Removing the men who have sex with men blood donation deferral: Informing risk models using Canadian public health surveillance data	8
The impact of COVID-19 on transfusion-dependent thalassemia patients of Karachi, Pakistan: A single-center experience	8
Platelet transfusion practice and related transfusion reactions in a large teaching hospital	7
The journey of blood continues	7
Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity	7
Recognizing the role of transfusion medicine specialist in the modern era	7
Transfusion at the border of the “intention-to-treat”, in the very aged person and in palliative care: A debate	6
Constraints and challenges in convalescent plasma collection amidst the Covid 19 pandemic- strategies and recommendations to overcome these	6
The detection, treatment of parvovirus B19 infection induced anemia in solid organ transplants: A case series and literature review of 194 patients	6
Thirty years of hemovigilance – Achievements and future perspectives	6
Variable response to therapeutic plasma exchange in pediatric anti-NMDA receptor encephalitis	6

Platelet transfusion in adults: An update	6
Risk factors for blood transfusion in Cesarean section: A systematic review and meta-analysis	6
Post-donation information management	6
Hemophilia care in Africa: Status and challenges	6
Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system)	6
Use of convalescent plasma in COVID-19 patients in China	6
Development of a scenario-based blood bank model to maximize reducing the blood wastage	6
Bioethical perspective of convalescent plasma therapy for COVID-19: A systematic review	5
COVID-19 convalescent plasma therapy and immunodeficiency	5
Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology	5
Non-cryopreserved peripheral blood stem cells autologous transplantation in multiple myeloma: Bicentric study	5
A case of COVID-19 Convalescent Plasma Donation in Greece: Directed donation for compassionate use in the donor's critically ill father	5
A quick “Can I donate blood” self-assessment tool amid the COVID-19 outbreak	5
Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants	5
An overview of red blood cell and platelet alloimmunisation in transfusion	5
Psychological assessment and lived experiences of recovered COVID-19 patients who presented for convalescent plasma donation	5
Review of blood donor deferral with emphasis on donor and patient safety	5
Is plasma donation ethics abused?	5
Adverse reactions following transfusion of blood components, with a focus on some rare reactions: Reports to the International Haemovigilance Network Database (ISTARE) in 2012–2016	5
SARS-CoV-2 infection in patients with β-thalassemia: The French experience	5
Protective effect of L-carnitine on platelet apoptosis during storage of platelet concentrate	5
Measuring public awareness about blood donation in Assir, South-Western Saudi Arabia	5
Plasma from donors convalescent from SARS-CoV-2 infection–A matter of priorities	5
Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India	5
Incidence and risk predictors analysis of adverse donor reactions in whole blood donation	5
SARS-CoV-2 variants in immunocompromised COVID-19 patients: The underlying causes and the way forward	4
Positive anti-SARS-CoV-2 rapid serological test results among asymptomatic blood donors	4
A novel scoring system for selecting the target patients of COVID-19 convalescent plasma therapy: A hypothesis	4
Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation	4
Indian blood donor selection guidelines: Review in the context of the ongoing COVID-19 pandemic	4
SARS COV-2- IgG antibodies in blood donors in pandemic – A game changer for policy makers	4
Cost of red blood cell transfusion; evaluation in a French academic hospital	4
Increasing unpaid plasma collection by blood establishments to ensure availability of plasma–derived medicinal products and blood components in Europe	4
The effect of red blood cell transfusion on peripheral tissue oxygen delivery and consumption in septic patients	4
Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic	4
Hemolysis: Mechanism and clinico-biological consequences	4
Maternal red blood cell alloimmunisation Working Party, literature review. RH blood group system: Rare specificities	4
Implementation of Low Titer Whole Blood for French overseas operations: O positive or negative products in massive hemorrhage?	3
Status analysis and evaluation of the blood scrap rate from 2015–2017 for a blood center in China	3
Hereditary haematologic disorders in Najaf province-Iraq	3
COVID-19, transfusion, and publishing ethics	3
Hepcidin-to-ferritin ratio: A potential novel index to predict iron overload-liver fibrosis in ß-thalassemia major	3
Transfusion safety in the Maghreb region	3
Epidemiological aspects and molecular characterization of the hepatitis B virus among blood donors in Lubumbashi, Democratic Republic of Congo	3
Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light	3
Mesenchymal – Stem and non-Stem – Cells: The name of the rose	3
Covid 19 vaccination: Latest guidelines on blood donor deferral in India	3
International collaboration for blood safety: The French—African experience	3
Nitric oxide donors offer protection to RBC from storage lesion	3
How do I/we forecast tomorrow’s transfusion? A focus on recipients’ profiles	3

Positive direct antiglobulin tests in cancer patients hospitalized with COVID-19: A brief report from India	3
Drug-induced immune hemolytic anemia investigation: Comparison between tube test and microcolumn agglutination (gel test) for the detection of drug-dependent antibodies in the presence of soluble drug	3
Viral metagenomics in Brazilian multiply transfused patients with sickle cell disease as an indicator for blood transfusion safety	3
Clinical performance evaluation of Elecsys HIV Duo, Anti-HCV II, HBsAg II, Anti-HBc II, and Syphilis assays for routine screening of first-time blood donor samples at a French blood donation center	3
Ethics in transfusion medicine: Are the intricate layers of ethics all universal? A global view	3
COVID-19 vaccination in the Indian blood donors: Adjudging the impact on the deferral period	3
Abnormal hemoglobin H band in myelodysplastic syndromes (MDS): A case report	2
Estimate of anti-SARS-CoV-2 spike IgG antibodies prevalence among Iranian population based on blood donations: A serial cross-sectional study during the third wave of the pandemic	2
Real-world data from India on clinical practices in the management of autoimmune haemolytic anaemia: A survey-based cross-sectional assessment	2
Clinical impact of rotational thromboelastometry in cardiac surgery	2
Effective and safe off-label use of caplacizumab treatment in a middle-aged obese male	2
Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021	2
Transfusional iron overload in patients with myelodysplastic syndromes: A 10-year retrospective survey from a French general hospital	2
Positive direct antiglobulin test in COVID-19 patients: Decision-making process	2
Deciphering the reasons for milky-white blood donor plasma	2
Transfusion medicine: Overtime paradigm changes and emerging paradoxes	2
ABO blood group should be considered and reported when red blood cell exchange transfusion is used to treat Plasmodium falciparum Malaria patients	2
Auto-anticorps anti-interférons de type I et COVID-19 sévère	2
How do we forecast tomorrow’s transfusion? Prehospital transfusion	2
Extended blood group phenotyping of donors from the lower and middle Himalayan region of Uttarakhand India: A pilot study	2
Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma	2
Iron-deficiency among blood donors: Donors’ opinion on iron supplementation strategy	2
The evolution of xenotransfusions through the ages	2
Prevalence of HEV RNA in Croatian blood donors	2
Cytokine dependent hematopoietic cell linker (CLNK) is highly elevated in blood transfusion dependent beta-thalassemia major patients	2
Utilizing SPIKES protocol for breaking bad news to sero-reactive blood donors	2
Improved neural network for predicting blood donations based on two emergent factors	2
Transfusion management of a Chinese pregnant woman with RHD*DEL1 allele	2
The interphase between immunoglobulin, the plasma industry and the public health, managing a finite resource	2
Pre-hospital transfusion of post-traumatic hemorrhage: Medical and regulatory aspects	2
Design and introduction of a rational mechanical eluting system for leukocyte recovery from leukoreduction filters: A cell differential approach	2
COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits	2
Trends in serological markers of transfusion transmissible infections in blood donations at the Bamenda Hospital-based Blood Service, Cameroon	2
O-negative blood shortage management in a university hospital: Impact of transfusing RhD-positive red blood cells to RhD-negative patients	2
Deferral of men who have sex with men from blood donation: Policy and change	2
How do we forecast tomorrow’s transfusion: The future of hematopoietic stem cell donation	2
Retrospective analysis of molecular biology mechanism of ABO blood group typing discrepancy among blood donors in Jinan blood station	2
Red-cell alloimmunization profile in multi transfused patients: Findings and insights of a blood transfusion service	2
Challenges in transfusion-transmitted infection screening in Sub-Saharan Africa	2
Does intraoperative transfusion during total knee arthroplasty reduce the need for transfusion after surgery?: A preliminary retrospective cohort study	1
Building capacities in research for blood services in Africa	1
Transient pseudothrombocytopenia (PTCP) in the neonate due to the mother	1
Factors influencing the return of inactive blood donors in a Cameroonian blood bank	1
The best use of the French donors’ gift – Continuing an ethical tradition	1
Reporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!	1
How do we forecast tomorrow’s transfusion: Infectious safety?	1
Towards equitable and sustainable availability of blood products in Zimbabwe: An analysis of strengths, weaknesses, opportunities and challenges	1
CL-15 Evaluation du risque résiduel de contamination bactérienne dans les concentrés plaquettaires traités par inactivation des pathogènes en France	1
The AfSBT Step-wise Accreditation program: Improving the quality in the African blood services	1
First successful pregnancy outcome after twelve abortions in a Tunisian-woman with the rare p phenotype	1
A prospective observational study to compare transfusion outcomes in ABO identical versus ABO non-identical single donor platelet concentrates: An experience from a tertiary healthcare center in India	1
L’éthique du don s’applique-t-elle de la même façon à tous les éléments du corps humain ?	1
Infectious diseases and the impact on transfusion medicine: A historical review and lessons for the future	1
Patient blood management in adults and children: What have we achieved, and what still needs to be addressed?	1
Delayed adverse reaction in donors after whole blood donation: Is it a matter of concern?	1
What is the optimal pretransfusion testing interval for multi-transfused patients? The University Hospital of Brest experience	1
COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors	1
Evaluation of beta-thalassemia in the fetus through cffDNA with multiple polymorphisms as a haplotype in the beta-globin gene	1
Transfusion management of Africans with RHD variants in China	1
There is an urgent need to adopt a pull-flow logic for the supply of RBCs to meet patients’ needs: A single center study	1
Don’t neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia	1
L-34 PBM - Gestion Personnalisée du Capital Sanguin du Patient en Péri-opératoire	1
The appropriateness of platelet transfusions in hematological patients and the potential for improvement	1
Transfusion-related respiratory complications in intensive care: A diagnosis challenge	1
Averting transfusion related catastrophe during blood administration: Backing transfusion bioethics	1
Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma	1
Role of Therapeutic Plasma Exchange in managing complement mediated thrombotic microangiopathy  – Case series	1
A case of severe hemolytic disease of newborn due to alloimmunization in primigravida	1
What convalescent plasma in treating severe acute respiratory infections of viral aetiology can hint for COVID-19? Evidence from a meta-analysis	1
Inactivation des pathogènes par le procédé Intercept® dans les concentrés plaquettaires : bilan de 3 ans de généralisation en France	1
Covid-19 convalescent plasma and SARS-CoV-2 viral variants	1
Covid-19 induced blood supply shortage: A Tunisian blood deposit perspective	1
How do we forecast tomorrows’ transfusion: Non-transfusional hemotherapy	1
How do we forecast tomorrow’s transfusion? — Next generation transfusion practices to improve recipient safety	1
Serological and molecular analysis of the B(A) subtype in China—A systematic review	1
Haploidentical haematopoietic stem cell transplantation for the treatment of severe aplastic anaemia patients with high-risk factors who lack an HLA-matched sibling donor	1
Reporting an abrupt-onset persistent hypotensive transfusion reaction in an Indian female patient	1
Effect of vibration of the vortex mixer on the red blood cells	1
Red cell alloimmunization in thalassaemia patients in India: Causes and mitigation strategies	1
Significant decrease in the transfusion rates during the COVID-19 pandemic in the North East of Iran	1

The role of funduscopy in severe thrombocytopenia: A prospective study	1
Prevalence and factors associated with vasovagal reaction among whole blood donors in hospital Universiti Sains Malaysia	1
Accurate detection of reemergent anti-donor ABO antibody is crucial for safe transfusion in ABO major incompatible HSCT patient after achieved the stages of full switch to donor type	1
The impact of a closed-loop electronic blood transfusion system on transfusion errors and staff time in a children's hospital	1
Vaccination and SARS-CoV-2 seroprevalence in blood donors: Correspondence	1
Homing of granulocytes transfused in perineal cellulitis in a RAC2 deficiency child monitored by chimerism quantification methods	1
Blood-Type-A is a COVID-19 infection and hospitalization risk in a Turkish cohort	1
Platelet transfusion therapy in the management of dengue patients: Role of fundus examination	1
Prenatal RHD genotyping in Croatia: preliminary results	1
Advancing blood transfusion safety using molecular detection in the country of Georgia	1
Determination of Rh type and gender using circulating cell-free fetal DNA in early pregnancy of Rh negative women in turkey	1
Transfusional iron overload in heavily transfused patients: Real-life data from a 10-year retrospective study of 611 cases managed in a French general hospital	1
Blood inventory management strategies to ensure adequacy of packed red blood cell stock	1
Reverse algorithm for screening of syphilis and trends in prevalence among blood donors in Coastal Karnataka	1
Impact of blood donor characteristics on quality of packed red blood cell concentrates	1
Significance of mandating a dedicated hemovigilance nurse and objectification of ‘imputability’ levels. Experience from a hospital-based blood centre in India	1
Estimation of genetic variation in the Secretor and Lewis genes in Iranian hospitalized children	1
Delayed haemolytic transfusion reaction due to Kidd antibodies	1
How do we forecast tomorrow’s transfusion? Applying social science approaches to meet tomorrow’s transfusion needs: Blood donors and donation	1
Supporting Garraud – and protecting transfusion	1
Comparative evaluation of DTT treated ABO isoagglutinin titres performed by two methods with solid phase red cell adhesion (SPRCA) titres	1
Carence en fer chez les donneurs de sang en France : état des lieux et perspectives de prévention	1
How do I/we forecast tomorrows’ transfusion: Blood components	1
Utilisation patterns of group O red blood cell transfusion by ABO and D non-identical recipients in large academic hospital	1
In vitro characteristics of cryopreserved platelet concentrates reconstituted by fresh frozen or lyophilized plasma	1
How do I/We forecast tomorrow’s transfusion? A series of experts’ proposals for changes in transfusion medicine	1
Renaissance in usage of excess plasma in blood banks	1
The Indian “blood storage centre” model for the provision of safe blood towards obstetric care in the remote regions of Uttarakhand	1
P-08 Vers un système d[StQuote]hémovigilance efficace et pérenne en Afrique francophone	1
Détection de mutations de résistance du VIH aux antirétroviraux : vers un dépistage rapide pré-thérapeutique ?	1
Maîtrise du risque transfusionnel en ES : réflexion sur la démarche a priori des risques	1
Positive direct antiglobulin tests in cancer patients on immune checkpoint inhibitors: A case series from India	1
P-23 Un cas d’EIR grave, mais surtout de diagnostic rebelle	1
Strawberry milky-white blood donor's plasma: signaling uncontrolled diabetic lipemia	1
History of blood ‘the ' unites us all	1
Modèle de transfusion in vitro pour étudier les globules rouges	1
Regulation of blood services in Africa	1
The European health data space proposal: An opportunity for improved blood donor protection and transfusion recipient care	1
Les limites d’une approche principiste dans l’éthique du don d’éléments et produits du corps humain. À propos d’exemples	1
Vers une meilleure compréhension des microvésicules dans les concentrés érythrocytaires	0
L-54 Le « patient blood management » dans la démarche RAAC	0
Profils éléctrophorétiques des protéines des donneurs de sang du CHU d’Oran	0
P-54 Le protocole transfusionnel donneur unique (PDU) en néonatalogie : vision du néonatalogiste	0
L-28 L’évaluation de la formation : une nécessité pour tous	0
P-59 Formateur une passion en mouvement	0
RAI 21 jours, aide à la prescription. Expérience aixoise	0
Groupage sanguin, redondances et pertinence	0
Formation des internes à la sécurité transfusionnelle et aux bonnes pratiques de prescription des PSL : bilan du Groupe des hémobiologistes et correspondants d’hémovigilance (GHCOH)	0
Validation des analyses d’immuno-hématologie « au fil de l’eau »	0
Validation de la préparation de MCP-IA DS par centrifugation/séparation avec CompoStop™ CI	0
No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis	0
Revue qualité produits : vers un outil simple et efficace	0
Groupe A faible, Para-Bombay et Bombay Réunion : quelles techniques simples au laboratoire pour orienter le diagnostic et le conseil transfusionnel ?	0
P-18 Anticorps anti-MNS4 non hémolysant chez une multipare	0
Apport de la géomatique dans l’optimisation de la filière sang rare et phénotypes d’intérêt	0
L-51 Gestion de l’hémorragie du post-partum	0
Expression of microRNAs during apheresis platelet storage up to day 14 in a blood bank in China	0
L-18 Les erreurs de receveurs et de patients destinataires de produits sanguins labiles (PSL) : données nationales et européennes	0
Therapeutic plasma exchange as a treatment modality for steroid refractory acute disseminated encephalomyelitis – A case report	0
P-17 Le TRALI (Transfusion Related Lung Injury) à l’unité d’hémovigilance du CRTS de Sfax, Tunisie	0
P-46 Risque résiduel de transmission du virus de l’hépatite C au Centre de Transfusion Sanguine de Yamoussoukro, Côte d’Ivoire, de 2017 à 2020	0
La transfusion au Maroc : mise au point sur la réglementation	0
P-61 Ethique transfusionnelle : quelle décision prendre ?	0
CL-05 Automatisation du titrage des anticorps anti-A et anti-B naturels et immuns	0
Étiologie des incompatibilités érythrocytaires : à propos de 10 649 cas	0
Ouverture au don des HSH : état des lieux et perspectives	0
Évaluation des anomalies liées à la non-utilisation du logiciel de gestion des donneurs en collecte mobile : bilan de 2 mois de prélèvements	0
Audit des transporteurs de produits sanguins labiles des établissements de santé de la région Centre-Val de Loire au 01/01/2020	0
What has changed after the COVID-19 pandemic in the publication process? A look-back to “Transfusion clinique et biologique”	0
Évaluation des MCP-IA traités avec un dispositif intégrant un CAD modifié	0
Traitement du purpura thrombotique thrombocytopénique auto-immun : un tournant décisif	0
Anti-SARS-CoV-2 spike IgG antibodies prevalence: Correspondence	0
Quelle prise en charge pour les donneurs de sang suspectés de présenter un phénotype McLeod lors de la Qualification Biologique du Don ?	0
P-03 La formation continue en sécurité transfusionnelle au CHU de Dijon : Comment l’améliorer ?	0
Table des matières	0
L-27 L’importance de l’animation de la formation	0
Intraoperative and immediate postoperative transfusion: Clinical-hematological profile of transfunded patients in a university hospital	0
L-10 Approvisionnement des Dépôts de Délivrance en EFS Occitanie	0
Les nouveaux systèmes de groupes sanguins érythrocytaires découverts en 2020 : CTL2, ABCC4, MAM, EMM et ABCC1	0
CL-10 Développement d’un outil informatique de surveillance des PSL présents dans les Dépôts d’Urgence Vitale de la région Occitanie	0
CL-17 Réalisation des prélèvements pour phénotypage érythrocytaire : une nouvelle enquête multicentrique et des pistes pour aller plus loin	0
L-62 Transfusion et patients COVID-19 au cours de la 1ère vague	0
P-38 Fiabilité des hémoglobinomètres utilisés au Centre National de Transfusion Sanguine d’Abidjan, Côte d’Ivoire	0
Comparaison qualitative des concentrés plaquettaires traités par Mirasol et Intercept	0
Incident grave de la chaîne : un risque minimisé par la procédure d’urgence vitale de l’EFS	0
Place de l’EDA élargi et de la recherche d’AF dans l’exploration d’une AHAI	0
Cadre d’action pour la promotion de l’accès universel à des produits sanguins sûrs dans la Région africaine de l’OMS	0
Revisiting the impact of serial therapeutic phlebotomy in polycythaemia on laboratory and clinical parameters using a fixed interval and fixed volume protocol	0
Hyper-hémolyse post-transfusionnelle retardée chez le drépanocytaire : à propos d’un cas	0
La possibilité d’un système expert dans la déclaration des EIR	0
P-50 Gestion des CGR irradiés en HFNO	0
Alteration in biochemical parameters during plateletpheresis in healthy donors: A compendious analysis	0
Editorial Board	0
Les vésicules extracellulaires dérivées des plaquettes sont impliquées dans la présentation des antigènes via leur MHC de classe I	0
L-61 Transfusion sanguine en Opération Extérieure : retour d’expérience d’une mission de l’opération Barkhane	0